Loading ...Pfizer wants to do three doses for children 6 months -5 years old versus two dose schedule — Says Its Low-Dose Vaccine Doesn’t Work
More doses = more money = more profit = higher share price = bwahahahahaha
“Amid clinical trials that are ongoing, the two drugmakers tested 3 micrograms of the vaccine in kids aged 6 months to less than 5 years of age. Children between 6 months and 2 years produced an immune response comparable to individuals aged 16 to 25 years after two adult doses of the mRNA vaccine (30 micrograms), the companies said.
However, the vaccine didn’t produce a significant immune response after the same low-dose regimen in children between the ages of 2 and 4, according to the companies. Pfizer and BioNTech said they will change their plans and will test three doses of their COVID-19 vaccine on children in that age group rather than the usual two doses.
Should the three-dose study prove successful, the companies said they will apply for an emergency use authorization from the Food and Drug Administration sometime in the first half of 2022.”